|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.74 |
-4.27 |
-47.64 |
3 |
6 |
1 |
80 |
302.354 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.74 |
-4.05 |
-46.87 |
3 |
6 |
1 |
80 |
302.354 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.02 |
-2.96 |
-43.45 |
3 |
6 |
1 |
88 |
302.354 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 75 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TYSY-3-E |
Thymidylate Synthase (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
7000 |
0.80 |
Binding ≤ 10μM
|
Z103205-4-O |
A431 (cluster #4 Of 4), Other |
Other |
18 |
1.20 |
Functional ≤ 10μM
|
Z103419-1-O |
UACC-812 (cluster #1 Of 2), Other |
Other |
3100 |
0.86 |
Functional ≤ 10μM
|
Z50425-14-O |
Plasmodium Falciparum (cluster #14 Of 22), Other |
Other |
7943 |
0.79 |
Functional ≤ 10μM
|
Z80035-6-O |
B16 (Melanoma Cells) (cluster #6 Of 7), Other |
Other |
8730 |
0.79 |
Functional ≤ 10μM
|
Z80054-2-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #2 Of 4), Other |
Other |
1500 |
0.91 |
Functional ≤ 10μM
|
Z80064-6-O |
CCRF-CEM (T-cell Leukemia) (cluster #6 Of 9), Other |
Other |
5000 |
0.82 |
Functional ≤ 10μM
|
Z80088-4-O |
CHO (Ovarian Cells) (cluster #4 Of 4), Other |
Other |
5000 |
0.82 |
Functional ≤ 10μM
|
Z80101-1-O |
COLO 320DM (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.93 |
Functional ≤ 10μM |
Z80120-3-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other |
Other |
6000 |
0.81 |
Functional ≤ 10μM |
Z80125-6-O |
DU-145 (Prostate Carcinoma) (cluster #6 Of 9), Other |
Other |
4800 |
0.83 |
Functional ≤ 10μM
|
Z80136-3-O |
FM3A (Breast Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
180 |
1.05 |
Functional ≤ 10μM
|
Z80156-6-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #6 Of 12), Other |
Other |
9500 |
0.78 |
Functional ≤ 10μM
|
Z80164-4-O |
HT-1080 (Fibrosarcoma Cells) (cluster #4 Of 6), Other |
Other |
9450 |
0.78 |
Functional ≤ 10μM
|
Z80166-8-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #8 Of 12), Other |
Other |
7300 |
0.80 |
Functional ≤ 10μM
|
Z80186-7-O |
K562 (Erythroleukemia Cells) (cluster #7 Of 11), Other |
Other |
2400 |
0.87 |
Functional ≤ 10μM
|
Z80192-2-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #2 Of 4), Other |
Other |
8320 |
0.79 |
Functional ≤ 10μM
|
Z80193-8-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #8 Of 12), Other |
Other |
970 |
0.94 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
9600 |
0.78 |
Functional ≤ 10μM
|
Z80268-1-O |
MKN-28 (Gastric Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2500 |
0.87 |
Functional ≤ 10μM |
Z80269-3-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
3000 |
0.86 |
Functional ≤ 10μM |
Z80347-2-O |
NUGC-3 (Gastric Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
4400 |
0.83 |
Functional ≤ 10μM |
Z80362-5-O |
P388 (Lymphoma Cells) (cluster #5 Of 8), Other |
Other |
609 |
0.97 |
Functional ≤ 10μM |
Z80390-6-O |
PC-3 (Prostate Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
16 |
1.21 |
Functional ≤ 10μM
|
Z80485-4-O |
SK-MEL-28 (Melanoma Cells) (cluster #4 Of 6), Other |
Other |
4500 |
0.83 |
Functional ≤ 10μM
|
Z80490-4-O |
SK-MES-1 (cluster #4 Of 4), Other |
Other |
310 |
1.01 |
Functional ≤ 10μM
|
Z80525-2-O |
SW48 (cluster #2 Of 2), Other |
Other |
5700 |
0.82 |
Functional ≤ 10μM |
Z80526-3-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #3 Of 6), Other |
Other |
8100 |
0.79 |
Functional ≤ 10μM
|
Z80532-5-O |
T-24 (Bladder Carcinoma Cells) (cluster #5 Of 6), Other |
Other |
4100 |
0.84 |
Functional ≤ 10μM
|
Z80583-6-O |
Vero (Kidney Cells) (cluster #6 Of 7), Other |
Other |
6810 |
0.80 |
Functional ≤ 10μM
|
Z80641-1-O |
791T Cell Line (cluster #1 Of 1), Other |
Other |
5500 |
0.82 |
Functional ≤ 10μM
|
Z80653-2-O |
9L (Glioma Cells) (cluster #2 Of 2), Other |
Other |
1000 |
0.93 |
Functional ≤ 10μM
|
Z80682-9-O |
A549 (Lung Carcinoma Cells) (cluster #9 Of 11), Other |
Other |
9200 |
0.78 |
Functional ≤ 10μM
|
Z80686-1-O |
AZ-521 Cell Line (cluster #1 Of 1), Other |
Other |
3900 |
0.84 |
Functional ≤ 10μM |
Z80712-5-O |
T47D (Breast Carcinoma Cells) (cluster #5 Of 7), Other |
Other |
600 |
0.97 |
Functional ≤ 10μM
|
Z80724-1-O |
C170 Cell Line (cluster #1 Of 1), Other |
Other |
2000 |
0.89 |
Functional ≤ 10μM
|
Z80742-2-O |
C6 (Glioma Cells) (cluster #2 Of 3), Other |
Other |
6100 |
0.81 |
Functional ≤ 10μM
|
Z80874-5-O |
CEM (T-cell Leukemia) (cluster #5 Of 7), Other |
Other |
9230 |
0.78 |
Functional ≤ 10μM
|
Z80928-7-O |
HCT-116 (Colon Carcinoma Cells) (cluster #7 Of 9), Other |
Other |
8510 |
0.79 |
Functional ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 8), Other |
Other |
9200 |
0.78 |
Functional ≤ 10μM
|
Z81024-6-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #6 Of 8), Other |
Other |
8500 |
0.79 |
Functional ≤ 10μM |
Z81034-5-O |
A2780 (Ovarian Carcinoma Cells) (cluster #5 Of 10), Other |
Other |
7210 |
0.80 |
Functional ≤ 10μM
|
Z81041-1-O |
Prostatic Carcinoma Cells (cluster #1 Of 2), Other |
Other |
6400 |
0.81 |
Functional ≤ 10μM
|
Z81043-2-O |
N592 (cluster #2 Of 2), Other |
Other |
5400 |
0.82 |
Functional ≤ 10μM
|
Z81048-1-O |
TSU (Prostatic Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3600 |
0.85 |
Functional ≤ 10μM
|
Z81115-6-O |
KB (Squamous Cell Carcinoma) (cluster #6 Of 6), Other |
Other |
4460 |
0.83 |
Functional ≤ 10μM
|
Z81121-1-O |
KKLS Cell Line (cluster #1 Of 1), Other |
Other |
6200 |
0.81 |
Functional ≤ 10μM |
Z81170-4-O |
LNCaP (Prostate Carcinoma) (cluster #4 Of 5), Other |
Other |
4900 |
0.83 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
9700 |
0.78 |
Functional ≤ 10μM
|
Z81252-9-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #9 Of 11), Other |
Other |
9600 |
0.78 |
Functional ≤ 10μM
|
Z81330-1-O |
SNU- (cluster #1 Of 1), Other |
Other |
2700 |
0.87 |
Functional ≤ 10μM |
Z81331-3-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #3 Of 6), Other |
Other |
9000 |
0.78 |
Functional ≤ 10μM
|
Z81335-3-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other |
Other |
9710 |
0.78 |
Functional ≤ 10μM
|
Z80156-3-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #3 Of 4), Other |
Other |
160 |
1.06 |
ADME/T ≤ 10μM
|
Z80192-2-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
7940 |
0.79 |
ADME/T ≤ 10μM
|
Z80193-4-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #4 Of 4), Other |
Other |
560 |
0.97 |
ADME/T ≤ 10μM
|
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
200 |
1.04 |
ADME/T ≤ 10μM
|
Z80901-2-O |
HaCaT (Keratinocytes) (cluster #2 Of 2), Other |
Other |
400 |
1.00 |
ADME/T ≤ 10μM
|
Z80928-2-O |
HCT-116 (Colon Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
2040 |
0.89 |
ADME/T ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 3), Other |
Other |
570 |
0.97 |
ADME/T ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
6610 |
0.81 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.59 |
-1.23 |
-13.33 |
2 |
4 |
0 |
66 |
130.078 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
-0.13 |
-4 |
-48.58 |
1 |
4 |
-1 |
69 |
129.07 |
0 |
↓
|
Mid
Mid (pH 6-8)
|
-0.13 |
-3.14 |
-32.57 |
1 |
4 |
-1 |
69 |
129.07 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-2.12 |
-6.04 |
-16.54 |
3 |
7 |
0 |
104 |
252.226 |
2 |
↓
|
|
|
Analogs
-
16407651
-
-
6475740
-
-
5248719
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.50 |
3.08 |
-12.19 |
0 |
5 |
0 |
54 |
328.364 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
5000 |
0.44 |
Functional ≤ 10μM
|
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
3800 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.49 |
5.85 |
-29.3 |
2 |
3 |
1 |
39 |
225.271 |
2 |
↓
|
Mid
Mid (pH 6-8)
|
3.49 |
5.53 |
-8.52 |
1 |
3 |
0 |
38 |
224.263 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 137 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AMPM2-2-E |
Methionine Aminopeptidase 2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5600 |
0.67 |
Binding ≤ 10μM |
Z101736-1-O |
Colletotrichum Coccodes (cluster #1 Of 1), Other |
Other |
190 |
0.86 |
Functional ≤ 10μM
|
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
2100 |
0.72 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.68 |
2.1 |
-8.63 |
1 |
2 |
0 |
33 |
145.161 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
1.68 |
2.86 |
-52.15 |
0 |
2 |
-1 |
36 |
144.153 |
0 |
↓
|
Lo
Low (pH 4.5-6)
|
1.68 |
2.58 |
-30.13 |
2 |
2 |
1 |
34 |
146.169 |
0 |
↓
|
|
|
Analogs
-
4520888
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 46 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.09 |
8.07 |
-21.27 |
0 |
3 |
1 |
19 |
284.408 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.52 |
6.29 |
-13.26 |
2 |
5 |
0 |
71 |
313.353 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 9 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TYRO-3-F |
Tyrosinase (cluster #3 Of 8), Fungal |
Fungi |
90 |
0.82 |
Binding ≤ 10μM
|
Z80136-5-O |
FM3A (Breast Carcinoma Cells) (cluster #5 Of 6), Other |
Other |
1100 |
0.70 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.08 |
5.55 |
-50.43 |
0 |
2 |
-1 |
40 |
163.196 |
1 |
↓
|
Mid
Mid (pH 6-8)
|
2.08 |
4.65 |
-14.09 |
1 |
2 |
0 |
37 |
164.204 |
1 |
↓
|
Mid
Mid (pH 6-8)
|
2.08 |
5.56 |
-50.71 |
0 |
2 |
-1 |
40 |
163.196 |
1 |
↓
|
|
|
Analogs
-
8322721
-
-
5513228
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.27 |
3.16 |
-13.31 |
0 |
5 |
0 |
54 |
328.364 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.15 |
8.06 |
-10.98 |
3 |
5 |
0 |
77 |
404.289 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.29 |
8.52 |
-14.79 |
3 |
5 |
0 |
77 |
325.393 |
5 |
↓
|
|
|
Analogs
-
4265274
-
-
6090974
-
-
12651207
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 20 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
50 |
0.57 |
Functional ≤ 10μM
|
Z80101-2-O |
COLO 320DM (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
5 |
0.65 |
Functional ≤ 10μM |
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
73 |
0.56 |
Functional ≤ 10μM |
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
14 |
0.61 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
41 |
0.57 |
Functional ≤ 10μM |
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
5 |
0.65 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
720 |
0.48 |
Functional ≤ 10μM
|
Z80268-2-O |
MKN-28 (Gastric Epithelial Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
28 |
0.59 |
Functional ≤ 10μM |
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
26 |
0.59 |
Functional ≤ 10μM |
Z80347-2-O |
NUGC-3 (Gastric Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
22 |
0.60 |
Functional ≤ 10μM |
Z80525-2-O |
SW48 (cluster #2 Of 2), Other |
Other |
16 |
0.61 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
14 |
0.61 |
Functional ≤ 10μM |
Z80682-9-O |
A549 (Lung Carcinoma Cells) (cluster #9 Of 11), Other |
Other |
1900 |
0.44 |
Functional ≤ 10μM |
Z80686-1-O |
AZ-521 Cell Line (cluster #1 Of 1), Other |
Other |
50 |
0.57 |
Functional ≤ 10μM |
Z81121-1-O |
KKLS Cell Line (cluster #1 Of 1), Other |
Other |
16 |
0.61 |
Functional ≤ 10μM |
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
22 |
0.60 |
Functional ≤ 10μM
|
Z81330-1-O |
SNU- (cluster #1 Of 1), Other |
Other |
45 |
0.57 |
Functional ≤ 10μM |
Z81335-3-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other |
Other |
47 |
0.57 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.68 |
-6.46 |
-14.66 |
4 |
8 |
0 |
125 |
262.193 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
-1.22 |
-9.21 |
-53.85 |
3 |
8 |
-1 |
128 |
261.185 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.34 |
-1.51 |
-10.91 |
3 |
5 |
0 |
77 |
325.393 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 4 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.99 |
-1.12 |
-13.26 |
3 |
7 |
0 |
95 |
385.445 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.32 |
7.53 |
-14.15 |
3 |
5 |
0 |
77 |
325.393 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.02 |
-1.66 |
-9.25 |
3 |
5 |
0 |
77 |
359.838 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.29 |
8.06 |
-9.97 |
3 |
4 |
0 |
68 |
295.367 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.40 |
6.67 |
-12.09 |
3 |
6 |
0 |
86 |
355.419 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.35 |
7.91 |
-16.44 |
3 |
6 |
0 |
86 |
355.419 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.73 |
8.78 |
-11.67 |
3 |
4 |
0 |
68 |
309.394 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.32 |
7.36 |
-12.03 |
3 |
5 |
0 |
77 |
325.393 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 25 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1700 |
0.35 |
Binding ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1700 |
0.35 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Binding ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.46 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2900 |
0.34 |
Binding ≤ 10μM |
Q25270-2-E |
Beta Tubulin (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2000 |
0.35 |
Functional ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Functional ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4920 |
0.32 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
530 |
0.38 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
660 |
0.38 |
Functional ≤ 10μM
|
TBB3-3-E |
Tubulin Beta-3 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB4A-3-E |
Tubulin Beta-4 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB4B-3-E |
Tubulin Beta-2 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
TBB8-3-E |
Tubulin Beta-8 Chain (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Functional ≤ 10μM
|
Z100495-1-O |
BMEC (Brain Microvessel Endothelial Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z100742-1-O |
MeWo (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
188 |
0.41 |
Functional ≤ 10μM |
Z103208-1-O |
AU565 (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z103407-2-O |
SW1990 (cluster #2 Of 2), Other |
Other |
250 |
0.40 |
Functional ≤ 10μM
|
Z50591-2-O |
Bos Taurus (cluster #2 Of 2), Other |
Other |
2000 |
0.35 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
18 |
0.47 |
Functional ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80013-2-O |
A10 (cluster #2 Of 2), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80035-5-O |
B16 (Melanoma Cells) (cluster #5 Of 7), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80064-4-O |
CCRF-CEM (T-cell Leukemia) (cluster #4 Of 9), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80071-2-O |
CEM-0 (T-cell Leukemia) (cluster #2 Of 2), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80099-3-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
2756 |
0.34 |
Functional ≤ 10μM
|
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
36 |
0.45 |
Functional ≤ 10μM
|
Z80121-1-O |
DMS-79 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
124 |
0.42 |
Functional ≤ 10μM
|
Z80125-9-O |
DU-145 (Prostate Carcinoma) (cluster #9 Of 9), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80136-2-O |
FM3A (Breast Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
42 |
0.45 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
94 |
0.43 |
Functional ≤ 10μM |
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM |
Z80193-1-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #1 Of 12), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80229-1-O |
MCF7-DOX (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
13 |
0.48 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
82 |
0.43 |
Functional ≤ 10μM
|
Z80284-3-O |
MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
16 |
0.47 |
Functional ≤ 10μM
|
Z80353-1-O |
OVCAR (cluster #1 Of 1), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
5400 |
0.32 |
Functional ≤ 10μM
|
Z80471-3-O |
SH-SY5 (Bone Marrow Neuroblastoma Cells) (cluster #3 Of 3), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z80485-3-O |
SK-MEL-28 (Melanoma Cells) (cluster #3 Of 6), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM |
Z80555-1-O |
TSGH (cluster #1 Of 1), Other |
Other |
45 |
0.45 |
Functional ≤ 10μM
|
Z80682-7-O |
A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other |
Other |
8 |
0.49 |
Functional ≤ 10μM
|
Z80697-3-O |
Bel-7402 (Hepatoma Cells) (cluster #3 Of 3), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80792-1-O |
Colon 26 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.49 |
Functional ≤ 10μM
|
Z80798-1-O |
CPT30 Cell Line (cluster #1 Of 1), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z80847-3-O |
FaDu (Pharyngeal Carcinoma Cells) (cluster #3 Of 3), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80852-2-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM
|
Z80874-2-O |
CEM (T-cell Leukemia) (cluster #2 Of 7), Other |
Other |
12 |
0.48 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z80900-1-O |
HA22T Cell Line (cluster #1 Of 1), Other |
Other |
2708 |
0.34 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z80967-2-O |
Hone-1 Cell Line (cluster #2 Of 2), Other |
Other |
7 |
0.50 |
Functional ≤ 10μM
|
Z81001-1-O |
TSGH 9201 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
38 |
0.45 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
6 |
0.50 |
Functional ≤ 10μM
|
Z81024-5-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #5 Of 8), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
2 |
0.53 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM
|
Z81065-3-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
5 |
0.51 |
Functional ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
10 |
0.49 |
Functional ≤ 10μM
|
Z81233-2-O |
M21 (Melanoma Cells) (cluster #2 Of 2), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM |
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
4 |
0.51 |
Functional ≤ 10μM |
Z81252-7-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #7 Of 11), Other |
Other |
43 |
0.45 |
Functional ≤ 10μM |
Z81331-6-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #6 Of 6), Other |
Other |
23 |
0.46 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3 |
0.52 |
Functional ≤ 10μM
|
Z100495-1-O |
BMEC (Brain Microvessel Endothelial Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.51 |
ADME/T ≤ 10μM
|
Z80013-2-O |
A10 (cluster #2 Of 2), Other |
Other |
23 |
0.46 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.52 |
ADME/T ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
0 |
0.00 |
ADME/T ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 4), Other |
Other |
2 |
0.53 |
ADME/T ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
0 |
0.00 |
ADME/T ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 5), Other |
Other |
5 |
0.51 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3 |
0.52 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.47 |
5.32 |
-10.67 |
1 |
5 |
0 |
57 |
316.353 |
6 |
↓
|
|
|
Analogs
-
1530861
-
-
5850156
-
-
5850183
-
-
6424763
-
-
19144226
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 66 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
400 |
0.41 |
Binding ≤ 10μM
|
KCNH2-5-E |
HERG (cluster #5 Of 5), Eukaryotic |
Eukaryotes |
2512 |
0.36 |
Binding ≤ 10μM
|
NQO2-1-E |
Quinone Reductase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Binding ≤ 10μM
|
PRIO-1-E |
Prion Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4000 |
0.34 |
Binding ≤ 10μM
|
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.45 |
Functional ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
400 |
0.41 |
Binding ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
77 |
0.45 |
Functional ≤ 10μM
|
Z100498-2-O |
Hepatocytes (cluster #2 Of 2), Other |
Other |
1900 |
0.36 |
Functional ≤ 10μM
|
Z101682-1-O |
BK Polyomavirus (cluster #1 Of 2), Other |
Other |
1700 |
0.37 |
Functional ≤ 10μM
|
Z102013-2-O |
Plasmodium Malariae (cluster #2 Of 2), Other |
Other |
14 |
0.50 |
Functional ≤ 10μM
|
Z102015-1-O |
Plasmodium Vivax (cluster #1 Of 1), Other |
Other |
90 |
0.45 |
Functional ≤ 10μM
|
Z50136-2-O |
Plasmodium Falciparum (isolate FcB1 / Columbia) (cluster #2 Of 3), Other |
Other |
167 |
0.43 |
Functional ≤ 10μM
|
Z50424-2-O |
Cryptosporidium Parvum (cluster #2 Of 2), Other |
Other |
27 |
0.48 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
100 |
0.45 |
Functional ≤ 10μM
|
Z50426-9-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other |
Other |
900 |
0.38 |
Functional ≤ 10μM
|
Z50468-2-O |
Giardia Intestinalis (cluster #2 Of 4), Other |
Other |
401 |
0.41 |
Functional ≤ 10μM
|
Z50473-4-O |
Plasmodium Berghei (cluster #4 Of 5), Other |
Other |
72 |
0.45 |
Functional ≤ 10μM
|
Z50474-1-O |
Plasmodium Yoelii (cluster #1 Of 1), Other |
Other |
106 |
0.44 |
Functional ≤ 10μM
|
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
40 |
0.47 |
Functional ≤ 10μM
|
Z81138-1-O |
ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other |
Other |
4000 |
0.34 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
9670 |
0.32 |
Functional ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 2), Other |
Other |
5100 |
0.34 |
ADME/T ≤ 10μM
|
Z80186-3-O |
K562 (Erythroleukemia Cells) (cluster #3 Of 3), Other |
Other |
32 |
0.48 |
ADME/T ≤ 10μM
|
Z80291-2-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #2 Of 3), Other |
Other |
64 |
0.46 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
8300 |
0.32 |
ADME/T ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 3), Other |
Other |
600 |
0.40 |
ADME/T ≤ 10μM
|
Z81135-5-O |
L6 (Skeletal Muscle Myoblast Cells) (cluster #5 Of 6), Other |
Other |
7700 |
0.33 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.01 |
10.55 |
-81.59 |
3 |
3 |
2 |
31 |
321.896 |
8 |
↓
|
|
|
Analogs
-
5850156
-
-
5850183
-
-
6424763
-
-
19144226
-
-
19144231
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 64 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
400 |
0.41 |
Binding ≤ 10μM
|
KCNH2-5-E |
HERG (cluster #5 Of 5), Eukaryotic |
Eukaryotes |
2512 |
0.36 |
Binding ≤ 10μM
|
NQO2-1-E |
Quinone Reductase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
1500 |
0.37 |
Binding ≤ 10μM
|
PRIO-1-E |
Prion Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4000 |
0.34 |
Binding ≤ 10μM
|
HRP1-1-E |
Histidine-rich Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.45 |
Functional ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
400 |
0.41 |
Binding ≤ 10μM
|
Z100275-1-O |
Hemozoin (cluster #1 Of 1), Other |
Other |
77 |
0.45 |
Functional ≤ 10μM
|
Z100498-2-O |
Hepatocytes (cluster #2 Of 2), Other |
Other |
1900 |
0.36 |
Functional ≤ 10μM
|
Z101682-1-O |
BK Polyomavirus (cluster #1 Of 2), Other |
Other |
1700 |
0.37 |
Functional ≤ 10μM
|
Z102013-2-O |
Plasmodium Malariae (cluster #2 Of 2), Other |
Other |
14 |
0.50 |
Functional ≤ 10μM
|
Z102015-1-O |
Plasmodium Vivax (cluster #1 Of 1), Other |
Other |
90 |
0.45 |
Functional ≤ 10μM
|
Z50136-2-O |
Plasmodium Falciparum (isolate FcB1 / Columbia) (cluster #2 Of 3), Other |
Other |
167 |
0.43 |
Functional ≤ 10μM
|
Z50424-2-O |
Cryptosporidium Parvum (cluster #2 Of 2), Other |
Other |
27 |
0.48 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
100 |
0.45 |
Functional ≤ 10μM
|
Z50426-9-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other |
Other |
900 |
0.38 |
Functional ≤ 10μM
|
Z50468-2-O |
Giardia Intestinalis (cluster #2 Of 4), Other |
Other |
401 |
0.41 |
Functional ≤ 10μM
|
Z50473-4-O |
Plasmodium Berghei (cluster #4 Of 5), Other |
Other |
72 |
0.45 |
Functional ≤ 10μM
|
Z50474-1-O |
Plasmodium Yoelii (cluster #1 Of 1), Other |
Other |
106 |
0.44 |
Functional ≤ 10μM
|
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
40 |
0.47 |
Functional ≤ 10μM
|
Z81138-1-O |
ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other |
Other |
4000 |
0.34 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
9670 |
0.32 |
Functional ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 2), Other |
Other |
5100 |
0.34 |
ADME/T ≤ 10μM
|
Z80186-3-O |
K562 (Erythroleukemia Cells) (cluster #3 Of 3), Other |
Other |
32 |
0.48 |
ADME/T ≤ 10μM
|
Z80291-2-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #2 Of 3), Other |
Other |
64 |
0.46 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
8300 |
0.32 |
ADME/T ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 3), Other |
Other |
600 |
0.40 |
ADME/T ≤ 10μM
|
Z81135-5-O |
L6 (Skeletal Muscle Myoblast Cells) (cluster #5 Of 6), Other |
Other |
7700 |
0.33 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.01 |
10.55 |
-81.48 |
3 |
3 |
2 |
31 |
321.896 |
8 |
↓
|
|
|
Analogs
-
3977743
-
-
3977744
-
-
4045293
-
-
1457
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 47 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TYSY-1-E |
Thymidylate Synthase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1 |
0.74 |
Binding ≤ 10μM
|
Z50472-2-O |
Toxoplasma Gondii (cluster #2 Of 4), Other |
Other |
960 |
0.50 |
Functional ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.51 |
Functional ≤ 10μM
|
Z80064-6-O |
CCRF-CEM (T-cell Leukemia) (cluster #6 Of 9), Other |
Other |
17 |
0.64 |
Functional ≤ 10μM
|
Z80136-1-O |
FM3A (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
9 |
0.66 |
Functional ≤ 10μM
|
Z80156-6-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #6 Of 12), Other |
Other |
12 |
0.65 |
Functional ≤ 10μM
|
Z80164-4-O |
HT-1080 (Fibrosarcoma Cells) (cluster #4 Of 6), Other |
Other |
180 |
0.56 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
5 |
0.68 |
Functional ≤ 10μM
|
Z80208-1-O |
L5178Y (Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.66 |
Functional ≤ 10μM
|
Z80682-9-O |
A549 (Lung Carcinoma Cells) (cluster #9 Of 11), Other |
Other |
9740 |
0.41 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
8500 |
0.42 |
Functional ≤ 10μM
|
Z81252-9-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #9 Of 11), Other |
Other |
210 |
0.55 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.72 |
-4.38 |
-16.24 |
3 |
7 |
0 |
105 |
246.194 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
-1.26 |
-7.12 |
-54.96 |
2 |
7 |
-1 |
108 |
245.186 |
2 |
↓
|
|